Mabano, Concepcion P.

HRN: 20-30-99  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/13/2022
05/20/2022
IV
4.5g
Q8
Pleural Effusion Right, Prob Sec To HAP
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: